ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Louisville, KY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Recurrence
Castration-Resistant Prostatic Cancer

Prostate Cancer trials near Louisville, KY, USA:

Locations recently updated

Open-label, Multicenter Study of Intramuscular PRL-02 Depot in Patients With Advanced Prostate Cancer

A Phase 1/2a, open-label, multicenter study of intramuscular (i.m.) PRL-02 depot in participants with advanced prostate cancer....

Enrolling
Prostate Cancer
mCSPC
Drug: docetaxel infusion
Drug: PRL-02 injection

Phase 1, Phase 2

Astellas
Astellas

Jeffersonville, Indiana, United States and 13 other locations

and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...

Active, not recruiting
Metastatic Castration-resistant Prostate Cancer
Drug: abiraterone acetate
Drug: olaparib

Phase 3

AstraZeneca
AstraZeneca

Jeffersonville, Indiana, United States and 131 other locations

Recently updated

patients with progressive metastatic castration-resistant prostate cancer (mCRPC).The following assessment of prostate cancer...

Active, not recruiting
Castration-resistant Prostate Cancer
Prostate Cancer Metastatic
Drug: Enzalutamide
Drug: HC-1119

Phase 3

Hinova Pharmaceuticals

Jeffersonville, Indiana, United States and 57 other locations

Locations recently updated

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...

Enrolling
Prostate Cancer
Drug: prednisone
Drug: enzalutamide

Phase 2

Astellas
Astellas

Jeffersonville, Indiana, United States and 225 other locations

cemiplimab, or in combination with REGN5678. REGN4336, cemiplimab and REGN5678 are a type of treatment for cancer called immunotherapy,and ...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: Cemiplimab
Drug: Sarilumab

Phase 1, Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Louisville, Kentucky, United States and 10 other locations

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...

Active, not recruiting
Prostatic Neoplasms
Drug: Apalutamide
Drug: Placebo

Phase 3

Aragon Pharmaceuticals

Jeffersonville, Indiana, United States and 388 other locations

in participants with high-risk, localized or locally advanced prostate cancer receiving primary radiation therapy (RT) results in a...

Active, not recruiting
Prostatic Neoplasms
Drug: Bicalutamide Placebo
Radiation: 74-80 Grays (units of radiation)

Phase 3

Aragon Pharmaceuticals

Jeffersonville, Indiana, United States and 271 other locations

A Phase 1 Dose Escalation and Expanded Cohort Study Of PF-06821497 In The Treatment Of Adult Patients With Relapsed/Refractory Small Cell Lung Cancer...

Enrolling
Castration Resistant Prostate Cancer (CRPC)
Small Cell Lung Cancer (SCLC)
Drug: PF-06821497

Phase 1

Pfizer
Pfizer

Louisville, Kentucky, United States and 100 other locations

The primary purpose of this study is to determine the pharmacokinetics (PK) and pharmacodynamics (PD) of Debio 4228.

Enrolling
Prostate Cancer
Drug: Debio 4228

Phase 2

Debiopharm
Debiopharm

Jeffersonville, Indiana, United States and 4 other locations

The purpose of this study was to evaluate the efficacy of enzalutamide plus androgen deprivation therapy (ADT) as measured by radiographic progressio...

Active, not recruiting
Metastatic Hormone Sensitive Prostate Cancer
Drug: Placebo
Drug: Enzalutamide

Phase 3

Astellas
Astellas

Jeffersonville, Indiana, United States and 202 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems